OSL oncosil medical ltd

5.69%

$1.16

Tailgater got tailgated by OSL, page-7

First 7 Last

Share
Profile

Follow
cafa

8,918 Posts.

32

17/01/16

20:36

Post #: 16812992
Share

Originally posted by redgum ↑

While all the aforementioned text is quite relevant from an industry point of view ie Oz biotechs are they worth investing in? the situation with OSL is that it is really no more than a binary punt until the science is proved. OSL at this stage simply boils down to will they be given an Eu approval or not.

Not all of us have the benefit of a medical or even a scientific back ground but even if you do I doubt if there is sufficient information out there to determine a chance of CE approval ie 90% chance of approval or just a 49% chance of approval. Perhaps the company knows already through its discussions in the approval process what the likely outcome is - there have been no indications either way. Is saying nothing after discussions a clue as to what might happen so let us keep our mouth shut or is it due to proper internal governance culture that obliges them to withhold any information until the full story is known?

So for me it is no more than a bet - yes there is approval or no there isn't approval. But I have to say I draw comfort from the fact that OSL have been able to attract what might be deemed industry experts out of the SRX camp and I suggest these people would not be attracted unless they felt that OSL had a good product and so were likely to succeed in a CE mark application. Thus I rate my bet at 55% to 45% in respect of being successful in their application and continue to hold.

TIS is an entirely different issue. In my opinion share holders were deceived by the management. I haven't yet been able to detect this 'quality' in the OSL team.

cheers

redgum

Expand

Redgum, when you say they have attracted SRX staff, you imply that these staff left SRX to join OSL.

I don't think so!

Charles Rowland terminated years ago. And as for the VP of clinical, she terminated SRX in July, and started with OSL in December. James, also way after to terminated from SRX.

Have you considered the possibility that OSL have deliberately targeted SRX staff as they know the moms and pops will read far too much into it. Triggers a few options I guess.

Last edited by cafa: 17/01/16

OSL Price at posting: 24.0¢ Sentiment: None Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.16		Change -0.070(5.69%)		Mkt cap ! $16.49M

Open	High	Low	Value	Volume
$1.25	$1.25	$1.11	$72.36K	60.96K

Buyers (Bids)

No.	Vol.	Price($)
1	9286	$1.16

Sellers (Offers)

Price($)	Vol.	No.
$1.18	412	1

View Market Depth

No.	Vol.	Price($)
1	9286	1.160
1	2126	1.150
1	7500	1.080
2	19761	1.050
1	2500	1.030

Price($)	Vol.	No.
1.180	412	1
1.200	8677	1
1.245	2418	1
1.250	46027	1
1.300	1500	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

OSL (ASX) Chart

Tailgater got tailgated by OSL, page-7

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Tailgater got tailgated by OSL, page-7

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News